Veozah is a non-hormonal prescription medicine ... I would be sure to address the FDA warning label and caution use,” adds Chuang. “I would restrict the use to patients that have failed ...

US drugs watchdog the FDA has placed its most serious warning - called a black box warning - on the non-hormonal drug fezolinetant, which is sold under the brand name Veozah and developed by ...

The once-daily oral drug has been cleared under the Veozah brand name for moderate to severe vasomotor symptoms (commonly known as hot flashes) in menopausal women, becoming a non-hormonal ...

Adding the results of EV-302 to the label makes it an option for cisplatin ... The picture was less encouraging for Veozah (fezolinetant), which became the first drug in the neurokinin 3 (NK3 ...